| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/10/2009 | EP2066353A1 Combination of zd6474 and bevacizumab for cancer therapy |
| 06/10/2009 | EP2066332A1 Flu vaccine admixture of mannan and flu antigen |
| 06/10/2009 | EP2066331A2 Methods for treating pain with reduced nuasea and vomiting |
| 06/10/2009 | EP2066330A2 Formulations of acetylsalicylic acid or its derivatives in soft capsules, exhibiting high stability |
| 06/10/2009 | EP2066329A2 Synthesis, methods of using, and compositions of cycloalkylmethylamines |
| 06/10/2009 | EP2066328A2 Combinations of class-i specific histone deacetylase inhibitors with proteasome inhibitors |
| 06/10/2009 | EP2066327A2 Histone deacetylase inhibitors with combined activity on class-i and class-iib histone deacetylases in combination with proteasome inhibitors |
| 06/10/2009 | EP2066326A2 Quinoxalinyl macrocyclic hepatitis c virus serine protease inhibitors |
| 06/10/2009 | EP2066325A2 Pharmaceutical compositions of aripiprazole |
| 06/10/2009 | EP2066324A2 Cycloalkanopyrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors |
| 06/10/2009 | EP2066323A2 Pharmaceutical compositions comprising combinations of an ampa/kainate antagonistic compound and an inhibitor of a multidrug resistance protein |
| 06/10/2009 | EP2066322A2 Hydrogenated pyrido [4,3-b] indoles such as dimebon for treating canine cognitive dysfunction syndrome |
| 06/10/2009 | EP2066321A2 Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs |
| 06/10/2009 | EP2066320A1 Methods and compositions for treating lymphoma and myeloma |
| 06/10/2009 | EP2066319A1 Benzotriazole kinase modulators |
| 06/10/2009 | EP2066318A2 Oxindole derivatives as anticancer agents |
| 06/10/2009 | EP2066317A2 Use of ion channel modulators in the prophylaxis and treatment of inflammatory and immunological diseases |
| 06/10/2009 | EP2066316A1 Azetidine and azetidone derivatives useful in treating pain and disorders of lipid metabolism |
| 06/10/2009 | EP2066315A1 Treatment of pain using satraplatin |
| 06/10/2009 | EP2066314A2 Use of theogallin for the treatment of mental concentration disorders, depression and dementia |
| 06/10/2009 | EP2066313A2 Topical compositions |
| 06/10/2009 | EP2066312A2 Use of chlorine guanabenz derivatives for treating polyglutamine expansion associated diseases |
| 06/10/2009 | EP2066311A2 Second line treatment of metastatic hormone refractory prostate cancer using satraplatin |
| 06/10/2009 | EP2066309A2 An oral pharmaceutical composition |
| 06/10/2009 | EP2066306A1 Process for preparing granules of hydrophilic vitamins |
| 06/10/2009 | EP2066302A2 Stabilizing compositions for antibiotics and methods of use |
| 06/10/2009 | EP2066301A1 Injectable pharmaceutical nimesulide solutions |
| 06/10/2009 | EP2066300A2 Self-preserved aqueous pharmaceutical compositions |
| 06/10/2009 | EP1983978A4 Novel application of topical anesthetics for modulation of neurogenic tremor |
| 06/10/2009 | EP1926486A4 Novel polymorphs of (s)-2,6-diamino-4,5,6,7-tetrahydrobenzothiazole monotartrate and methods of producing and using the same |
| 06/10/2009 | EP1883401A4 Anti-microbial agent |
| 06/10/2009 | EP1844001B1 Metabolites of 2-arylpropionic acid derivatives and pharmaceutical compositions containing them |
| 06/10/2009 | EP1805142A4 Novel pyridine compounds, process for their preparation and compositions containing them |
| 06/10/2009 | EP1730144B1 Substituted 1,4,8-triazaspiro¬4.5 decan-2-one compounds |
| 06/10/2009 | EP1718649B1 Imidazo 1,2-c pyrimidinylacetic acid derivatives |
| 06/10/2009 | EP1713805B1 Kinase inhibitors |
| 06/10/2009 | EP1711499B1 Fused pyrrolocarbazoles and methods for the preparation thereof |
| 06/10/2009 | EP1685254B1 Oncolytic herpes simplex virus encoding a heterologous nitroreductase |
| 06/10/2009 | EP1601673B1 Fused heterocycles and uses thereof |
| 06/10/2009 | EP1599461B1 THIOLACTONES AS NAALADase INHIBITORS |
| 06/10/2009 | EP1597251B1 Pyrimidine compounds |
| 06/10/2009 | EP1575981B1 Angiogenic acting tri-sulphate steroids and uses thereof |
| 06/10/2009 | EP1532105B1 Anthranyl derivatives having an anticholecystokinin activity (anti-cck-1), a process for their preparation, and pharmaceutical use thereof |
| 06/10/2009 | EP1530470B1 Selective estrogen receptor modulators containing a phenylsulfonyl group |
| 06/10/2009 | EP1474385B1 Urea linker derivatives for use as ppar modulators |
| 06/10/2009 | EP1443892B1 Use of cationic surfactant as antimicrobial activity enhancer in deodorants and oral care |
| 06/10/2009 | EP1414797B9 Hepatitis c virus polymerase inhibitors with a heterobicylic structure |
| 06/10/2009 | EP1385490B1 Adhesive emulsion for medical purposes made from ethylene-vinyl acetate copolymers and adhesive resins |
| 06/10/2009 | EP1319003B1 Xanthine phosphodiesterase v inhibitors |
| 06/10/2009 | EP1289573B1 A medicinal aerosol antidiabetics formulation |
| 06/10/2009 | EP1273587B1 Process for the preparation of a 3-vinylcephem compound |
| 06/10/2009 | EP1135122B1 Use of amtolmetin guacyl as for the treatment of intestinal inflammations |
| 06/10/2009 | EP0854870B1 Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
| 06/10/2009 | EP0831892B1 Multimeric, recombinant urease vaccine |
| 06/10/2009 | EP0732924B1 Tts containing a parasympathomimetic and a parasympatholytic agent |
| 06/10/2009 | DE202009001822U1 Prophylaxemittel gegen Krebskrankheiten und erhöhte Hautspannungen Prophylaxis for cancer diseases and increased skin tension |
| 06/10/2009 | DE102007058842A1 Arzneimittel Drug |
| 06/10/2009 | DE102007058747A1 Nichtsteroidale Progesteronrezeptor-Modulatoren Non-steroidal progesterone receptor modulators |
| 06/10/2009 | CN101454012A Method of enhancing the control of viruses on skin |
| 06/10/2009 | CN101454011A Tri and tetra-oligo-saccharides suitable as agglutination agents for enteric pathogens |
| 06/10/2009 | CN101454010A Antifungal agents |
| 06/10/2009 | CN101454009A Use of (S)-roscovitine for manufacturing a medicine |
| 06/10/2009 | CN101454008A Dental appliance cleanser |
| 06/10/2009 | CN101454007A Adhesive |
| 06/10/2009 | CN101454006A Thiazolidinedione analogues for the treatment of hypertension and for lowering lipids |
| 06/10/2009 | CN101454005A Thiazolidinedione analogues for the treating metabolic inflammation mediated disease |
| 06/10/2009 | CN101454004A Pyridone sulfonamides and pyridone sulfamides as mek inhibitors |
| 06/10/2009 | CN101454003A Oral composition comprising 3-[5-[4-(cyclopentyloxy) -2-hydroxybenzoyl]-2-[(3-hydroxy-1,2-benzisoxazol-6- yl)methoxy]phenyl]propionic acid or salt thereof |
| 06/10/2009 | CN101454002A Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases |
| 06/10/2009 | CN101454001A Treatment of erectile dysfunction and libido enhancement |
| 06/10/2009 | CN101454000A Anti-fatigue agent containing amino acid composition |
| 06/10/2009 | CN101453999A Treatment of renal disorders, diabetic nephopathy and dyslipidemias |
| 06/10/2009 | CN101453998A Pharmaceutical composition for the treatment of viral infections and/or tumor diseases by inhibiting protein folding and protein breakdown |
| 06/10/2009 | CN101450950A Tetracyclic heterocompounds as estrogen receptor modulators |
| 06/10/2009 | CN101450934A Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 06/10/2009 | CN101450212A Solid pharmaceutical dispersions with enhanced bioavailability |
| 06/10/2009 | CN101450073A New medical use of lily polysaccharide and lily polysaccharide preparation |
| 06/10/2009 | CN101450072A Lily polysaccharide nutrient health-care oral liquid |
| 06/10/2009 | CN101450071A Lily polysaccharide capsule |
| 06/10/2009 | CN101450070A Anti-melancholia medicine using Chinese date Camp as raw material |
| 06/10/2009 | CN101450069A Soluble powder for treating poultry respiratory infection |
| 06/10/2009 | CN101450068A Premixing agent for preventing and treating livestock nematodiasis |
| 06/10/2009 | CN101450067A Premixing agent for treating and preventing livestock and poultry respiratory disease |
| 06/10/2009 | CN101450066A Soluble powder for treating poultry bacterial and mycoplasma infection |
| 06/10/2009 | CN101450065A Powder for treating livestock and poultry mycoplasma infection |
| 06/10/2009 | CN101450064A Medicine use of ginsenoside or mixture thereof |
| 06/10/2009 | CN101450063A Oral medicine for treating hypochondria |
| 06/10/2009 | CN101450062A Medicine composition for treating melancholia using multi-target receptor after-action mechanism |
| 06/10/2009 | CN101450061A Soluble powder for treating poultry bacterial infection |
| 06/10/2009 | CN101450060A Soluble powder for treating livestock and poultry coccidiosis |
| 06/10/2009 | CN101450059A Anthelmintic agent and preparation method thereof |
| 06/10/2009 | CN101450058A Soluble powder for treating dog and cat bacterial infection |
| 06/10/2009 | CN101450057A Use of oxicam compounds |
| 06/10/2009 | CN101450056A New use of sodium ion channel blocker in treating biology drug resistance of antibiotic |
| 06/10/2009 | CN101450055A Soluble powder for treating livestock and poultry bacterial infection and parasitic disease |
| 06/10/2009 | CN101450054A Soluble powder for treating poultry bacterial infection |
| 06/10/2009 | CN101450053A Metronidazole stomatocace double-layer paster and preparation method thereof |
| 06/10/2009 | CN101450052A Use of black mulberry extract in preparing tyrosinase inhibitor |
| 06/10/2009 | CN101450051A Monomer salvianolic acid B injection and preparation method thereof |
| 06/10/2009 | CN101450050A Taxane type freeze-dried powder injection and preparation method thereof |